
Shin Lin Chen
Examiner (ID: 17983, Phone: (571)272-0726 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1633, 1632 |
| Total Applications | 1467 |
| Issued Applications | 727 |
| Pending Applications | 150 |
| Abandoned Applications | 592 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18558737
[patent_doc_number] => 11723962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Cell-based neoantigen vaccines and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/098808
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 29
[patent_no_of_words] => 23668
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098808
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098808 | Cell-based neoantigen vaccines and uses thereof | May 3, 2017 | Issued |
Array
(
[id] => 17436116
[patent_doc_number] => 11261430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells
[patent_app_type] => utility
[patent_app_number] => 16/098359
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 34091
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098359
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098359 | Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells | May 2, 2017 | Issued |
Array
(
[id] => 18887701
[patent_doc_number] => 11866462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Recombinant adeno-associated viral vectors
[patent_app_type] => utility
[patent_app_number] => 16/098814
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 11506
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098814 | Recombinant adeno-associated viral vectors | May 2, 2017 | Issued |
Array
(
[id] => 12000352
[patent_doc_number] => 20170304507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'Extracellular Matrix Sheet Structures'
[patent_app_type] => utility
[patent_app_number] => 15/496297
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7341
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15496297
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/496297 | Extracellular matrix sheet structures | Apr 24, 2017 | Issued |
Array
(
[id] => 14930529
[patent_doc_number] => 20190300902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => STABLE PSEUDOTYPED LENTIVIRAL PARTICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/095098
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095098
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095098 | Stable pseudotyped lentiviral particles and uses thereof | Apr 20, 2017 | Issued |
Array
(
[id] => 14075067
[patent_doc_number] => 20190086421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHOD FOR PRODUCING ANIMAL MODEL OF PRETERM BIRTH AND ANIMAL MODEL OF PRETERM BIRTH PRODUCED BY THE METHOD
[patent_app_type] => utility
[patent_app_number] => 16/084092
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084092 | Method for producing animal model of preterm birth and animal model of preterm birth produced by the method | Apr 17, 2017 | Issued |
Array
(
[id] => 11969870
[patent_doc_number] => 20170274024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'AAV Vectors Targeted to Oligodendrocytes'
[patent_app_type] => utility
[patent_app_number] => 15/488966
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24365
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488966
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488966 | AAV Vectors Targeted to Oligodendrocytes | Apr 16, 2017 | Abandoned |
Array
(
[id] => 14040887
[patent_doc_number] => 20190076550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => GENE THERAPY FOR TREATING HEMOPHILIA B
[patent_app_type] => utility
[patent_app_number] => 16/093796
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093796 | Gene therapy for treating hemophilia B | Apr 12, 2017 | Issued |
Array
(
[id] => 11850250
[patent_doc_number] => 20170224741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'MODULATION OF STEM CELLS USING ZINC FINGER PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/486731
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28757
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486731
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/486731 | Modulation of stem cells using zinc finger proteins | Apr 12, 2017 | Issued |
Array
(
[id] => 17497768
[patent_doc_number] => 11286461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Method to prepare sperm
[patent_app_type] => utility
[patent_app_number] => 16/089862
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 48
[patent_no_of_words] => 18501
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089862 | Method to prepare sperm | Mar 30, 2017 | Issued |
Array
(
[id] => 14182731
[patent_doc_number] => 20190111070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => METABOLICALLY STABILIZED DOUBLE STRANDED mRNA
[patent_app_type] => utility
[patent_app_number] => 16/090468
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090468 | Metabolically stabilized double stranded mRNA | Mar 30, 2017 | Issued |
Array
(
[id] => 14102905
[patent_doc_number] => 20190093128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => METHODS FOR GENOME EDITING IN ZYGOTES
[patent_app_type] => utility
[patent_app_number] => 16/084158
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084158 | METHODS FOR GENOME EDITING IN ZYGOTES | Mar 29, 2017 | Abandoned |
Array
(
[id] => 14214631
[patent_doc_number] => 20190119700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => Lentiviral Vector Capable of Directly Reflecting Type I Interferon Response, Preparation Method Thereof, and Applications Thereof
[patent_app_type] => utility
[patent_app_number] => 16/092796
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092796 | Lentiviral vector capable of directly reflecting type I interferon response, preparation method thereof, and applications thereof | Mar 28, 2017 | Issued |
Array
(
[id] => 14439037
[patent_doc_number] => 20190177391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => ANGIOPOIETIN-LIKE PROTEIN 8 (ANGPTL8)
[patent_app_type] => utility
[patent_app_number] => 16/089128
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089128 | ANGIOPOIETIN-LIKE PROTEIN 8 (ANGPTL8) | Mar 28, 2017 | Abandoned |
Array
(
[id] => 17280456
[patent_doc_number] => 11197467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes
[patent_app_type] => utility
[patent_app_number] => 15/468652
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 81
[patent_no_of_words] => 58431
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468652
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468652 | Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes | Mar 23, 2017 | Issued |
Array
(
[id] => 11728045
[patent_doc_number] => 20170189488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'CODON-OPTIMIZED RECOMBINANT PLASMID, METHOD OF STIMULATING PERIPHERAL NERVE REGENERATION, AND METHOD OF TREATING NERVE DAMAGE IN HUMANS'
[patent_app_type] => utility
[patent_app_number] => 15/460668
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6254
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15460668
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/460668 | CODON-OPTIMIZED RECOMBINANT PLASMID, METHOD OF STIMULATING PERIPHERAL NERVE REGENERATION, AND METHOD OF TREATING NERVE DAMAGE IN HUMANS | Mar 15, 2017 | Abandoned |
Array
(
[id] => 16238623
[patent_doc_number] => 20200255857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING BETA HEMOGLOBINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 16/085480
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085480
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085480 | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING BETA HEMOGLOBINOPATHIES | Mar 13, 2017 | Abandoned |
Array
(
[id] => 11706585
[patent_doc_number] => 20170175084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'TUMOR STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/452138
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22139
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15452138
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/452138 | TUMOR STEM CELLS | Mar 6, 2017 | Abandoned |
Array
(
[id] => 17875765
[patent_doc_number] => 11447768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Molecular cell diary system
[patent_app_type] => utility
[patent_app_number] => 16/078272
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 18304
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078272
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078272 | Molecular cell diary system | Feb 28, 2017 | Issued |
Array
(
[id] => 16932741
[patent_doc_number] => 20210198630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => CARTILAGE-DERIVED PROGENITOR CELL LINES
[patent_app_type] => utility
[patent_app_number] => 16/081029
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081029
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081029 | Cartilage-derived mesenchymal cell lines | Feb 27, 2017 | Issued |